Abstract
The Italian Medicines Agency (AIFA) negotiates agreements to manage the pharmaceutical expenditure, especially for high-cost drugs. The analysis aimed to assess the most relevant variables impacting medicine prices (Average Price - AP) which account for both discounts negotiated with AIFA and further discounts applied in tenders.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
